Why the study?
Myocardial infarction causes the loss of millions of cardiomyocytes, and current treatments do not address this root issue.
This review outlines current and emerging strategies for cardiomyocyte regeneration post-myocardial infarction, focusing on in vivo and in vitro models.
Synthesizes post-MI regeneration strategies; extends preclinical models while leaving clinical translation open.
Myocardial infarction (MI) causes the loss of millions of cardiomyocytes, and current treatments do not address this root issue. New therapies focus on stimulating cardiomyocyte division in the adult heart, inspired by the regenerative capacities of lower vertebrates and neonatal mice. This review explores strategies for heart regeneration, offers insights into cardiomyocyte proliferation, evaluates in vivo models, and discusses integrating in vitro human cardiac models to advance cardiac regeneration research.
No takes yet. Share an insight, caveat, or question.
Bois et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: